Willdan Group, Inc. (WLDN) stock: key figures, P/E, revenue and dividend
Industrials · United States · ISIN US96924N1000
Willdan Group, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 681.55 m USD |
| Gross profit | 255.68 m USD |
| Operating income | 44.15 m USD |
| EBIT | 39.99 m USD |
| Net income | 52.56 m USD |
| Diluted EPS – continuing operations | 3.49 USD |
Full history since 2001, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Willdan Group, Inc.
Willdan Group, Inc., a technical services company, focuses on the provision of energy and infrastructure solutions in the United States and Canada. The company operates in two segments: Energy, and Engineering and Consulting. The Energy segment offers in-depth energy planning studies, economic analysis, modeling and forecasting software, decarbonization, program design and implementation, energy efficiency, turnkey energy and infrastructure projects, grid modernization, and utility-scale electrical engineering and construction management services. It serves investor-owned and municipal utilities, as well as investors and hyperscalers, and state and local governments. The Engineering and Consulting segment provides municipal and civil engineering, building and safety, code enforcement, fire plan and inspection, city engineering, construction management, design engineering, planning, and financial and municipal advisory services. It serves state and local governments, school districts, and utility districts. The company was founded in 1964 and is headquartered in Anaheim, California.
More stocks
- NewPrinces SpA (NWL.MI)
- HighPeak Energy, Inc. (HPK)
- MYERS INDUSTRIES INC (MYE)
- Sunwave Communications Co Ltd (002115.SZ)
- Seneca Foods Corp (SENEB)
- Nhn Entertain (181710.KS)
- JPG (5323.KL)
- Capitol Federal Financial, Inc. (CFFN)
- Innovative Medical Management Co Ltd (002173.SZ)
- CNB FINANCIAL CORP/PA (CCNE)
- Compagnie des Alpes SA (CDA.PA)
- Janux Therapeutics, Inc. (JANX)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.